Fair value losses enlarging net losses

Hong Kong IPO disclosure precedents · 133 companies, 133 items

Redemption or repurchase obligations (e.g. put options over Pre-IPO shares) measured at fair value whose fair-value or carrying-amount changes produce losses that materially enlarge the issuer's net loss, including where the obligation is later terminated.

2026-04-09Prospectus

The holders of preferred shares have the right to require us to redeem some or all of the preferred shares held by them upon certain redemption events that are not entirely within our control.

Financial Information · p. 241

Our redemption liabilities increased from RMB3,286.7 million as of December 31, 2023 to RMB3,736.1 million as of December 31, 2024, and further increased to RMB4,091.5 million as of December 31, 2025, primarily due to the continuous increase in the carrying amount from the existing series of financing recognized.

Financial Information · p. 255

These convertible redeemable preferred shares will be re-designated from liabilities to equity upon automatic conversion into ordinary shares at the time of the Listing.

Financial Information · p. 241
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
Casstime Holdings Ltd.开思时代控股有限公司

For the years ended December 31, 2023, 2024 and 2025, we recorded loss on fair value change on financial liabilities at fair value through profit or loss of RMB432.0 million, RMB318.5 million and RMB342.8 million, respectively.

Financial Information · p. 208

During the Track Record Period, we recorded financial liabilities at fair value through profit or loss of RMB2,606.8 million, RMB3,021.9 million, RMB3,451.7 million and RMB3,451.7 million as of December 31, 2023, 2024 and 2025 and February 28, 2026, respectively.

Financial Information · p. 228
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
CHANDO GLOBAL HOLDING LIMITED自然堂全球控股有限公司

As of December 31, 2023, 2024, 2025 and February 28, 2026, we had financial liabilities at fair value through profit or loss of nil, RMB410.2 million, RMB773.4 million and RMB773.4 million, respectively, mainly representing the redemption liabilities relating to our Series A Preferred Shares.

Financial Information · p. 223

Fair value losses of financial liabilities at fair value through profit or loss represent changes in the fair value of the convertible preferred shares issued by us and relate to changes in our valuation.

Financial Information · p. 202
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-01Application Proof

In 2023, 2024 and 2025, we recorded fair value changes of preferred shares, warrants and convertible notes of RMB438.7 million, RMB328.0 million and RMB202.6 million, respectively, accounting for 49.7%, 37.2% and 23.0% of the net loss for the respective years.

Business · p. 148

Upon completion of the [REDACTED], such fair value changes will cease to arise, thereby materially improving our financial position.

Business · p. 148

Our preferred shares, warrants and convertible notes increased from RMB2,311.1 million as of December 31, 2023 to RMB2,676.8 million as of December 31, 2024, and further increased to RMB2,924.4 million as of December 31, 2025, which was primarily due to the increased valuation of such shares.

Financial Information · p. 198
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-31Application Proof

We recorded fair value losses on convertible and redeemable preferred shares of RMB114.0 million and RMB148.3 million in 2024 and 2025, respectively.

Financial Information · p. 228

As of December 31, 2024 and 2025, our convertible and redeemable preferred shares amounted to RMB857.7 million and RMB1,318.5 million, respectively.

Financial Information · p. 233
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-31Application Proof
Hefei Youibot Robotics Co., Ltd.合肥优艾智合机器人股份有限公司

As of December 31, 2023, 2024 and 2025, our redemption liabilities amounted to RMB1,227.2 million, RMB1,456.1 million and RMB2,121.1 million, respectively.

Financial Information · p. 255

We recognized losses from changes in the carrying amount of redemption liabilities of RMB118.5 million, RMB108.8 million and RMB249.4 million in 2023, 2024 and 2025, respectively.

Financial Information · p. 240

We recognized the redemption liabilities at their present value of the redemption amount, with changes in such carrying amounts being booked in profit or loss, arising from redemption rights issued to [REDACTED] Investors.

Summary · p. 12
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-31Application Proof
TOP TOY International Group Limited大潮玩国际集团有限公司

Changes in the carrying amount of redemption liabilities | – | – | 158,491

Summary · p. 11

Our management considers that (i) equity-settled share-based payment expenses and changes in the carrying amount of redemption liabilities are non-cash in nature and do not result in cash outflow, and (ii) [REDACTED] are expenses relating to the [REDACTED].

Summary · p. 11
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-29Application Proof

Our fair value losses of convertible redeemable preferred shares amounted to a loss of RMB185.6 million, RMB328.1 million and RMB339.0 million in 2023, 2024 and 2025, respectively.

Financial Information · p. 224

Our financial liabilities related to convertible and redeemable preferred shares gradually increased from RMB2,489.8 million as of December 31, 2023 to RMB2,707.9 million as of December 31, 2024 and RMB2,767.8 million as of December 31, 2025, primarily due to our increased market valuation.

Financial Information · p. 236

These special rights shall all be automatically terminated upon the [REDACTED] except for the redemption rights which shall be suspended on the date immediately before the date of our first submission of [REDACTED] application to the Stock Exchange and shall be restored under certain circumstances.

Financial Information · p. 224
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-27Application Proof
Shenzhen Xiaokuo Technology Co., Ltd.深圳小阔科技股份有限公司

As of December 31, 2023, 2024 and 2025 and February 28, 2026, we recorded redemption liabilities of RMB548.4 million, RMB579.2 million, RMB581.9 million and RMB585.6 million.

Financial Information · p. 174

We recorded changes in the carrying amount of redemption liabilities of RMB11.1 million, RMB30.8 million and RMB56.9 million in 2023, 2024 and 2025.

Financial Information · p. 161

Changes in the carrying amount of the redemption liabilities are neither related to the ordinary course of our business nor indicative of our ongoing core operating performance.

Summary · p. 7
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-20Application Proof
Atom Therapeutics Co., Ltd.杭州新元素药业股份有限公司

Redemption liabilities at FVTPL arise from the preferred shares issued by our Company under various financing agreements.

Financial Information · p. 250

We incurred net other losses of RMB333.2 million in 2025, primarily driven by the fair value loss on redemption liabilities at FVTPL of RMB334.9 million in relation to the fair value change of our preferred shares.

Financial Information · p. 252

Our redemption liabilities at FVTPL increased by 41.4% from RMB1,214.5 million as of December 31, 2024 to RMB1,716.9 million as of December 31, 2025, primarily due to higher fair value of our preferred shares resulting from financing activities during the year.

Financial Information · p. 256
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-16Application Proof

Our preferred shares and other financial liabilities at FVPL increased from RMB2,942.1 million as of December 31, 2023 to RMB3,728.2 million as of December 31, 2024 and further increased to RMB4,230.0 million as of December 31, 2025 due to the increased valuation of our company as the result of improvement in our business operations and financial results.

Financial Information · p. 193

Fair value changes of preferred shares and other financial liabilities were negative RMB136.5 million, negative RMB323.3 million, and negative RMB238.6 million in 2023, 2024, and 2025, respectively, mainly due to the increase in the fair value of our Company during the Track Record Period, driven by the improvements in operating performance and market conditions.

Financial Information · p. 182
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-16Prospectus
JIANGSU NEW VISION AUTOMOTIVE ELECTRONICS CO., LTD.江苏泽景汽车电子股份有限公司02632.HK

(i) an increase in the fair value loss of our redemption liabilities on equity as a result of the redemption liabilities arising from the preferred shares that we issued during Pre-IPO financing. We do not expect to record any further changes in fair value of our convertible preferred shares after the Listing as such convertible preferred shares will be re-designated from liabilities to equity as a result of the automatic conversion into ordinary shares upon the Listing;

Summary · p. 23

We define adjusted (loss)/profit for the year/period (non-IFRS measure) as loss for the year/period adjusted by adding back (i) fair value losses on redemption liabilities on equity shares, (ii) share-based payment expenses and (iii) listing expenses.

Summary · p. 13
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-02-27Application Proof

A substantial portion of our loss during the Track Record Period was attributable to non-cash and non-recurring items, including (i) fair value losses on convertible redeemable preferred shares of €1.5 million, €29.6 million, €25.8 million and €30.1 million in 2023, 2024 and the nine months ended September 30, 2024 and 2025, respectively, which will cease upon automatic conversion of all preferred shares into ordinary shares upon [REDACTED];

Business · p. 131

When the redemption rights held by the shareholders of the convertible redeemable preferred shares are unconditionally terminated, redemption liabilities are reclassified and credited to equity.

Financial Information · p. 182

As of December 31, 2023 and 2024, September 30, 2025 and January 31, 2026, our convertible redeemable preferred shares amounted to €58.7 million, €98.4 million, €118.0 million and €124.9 million, respectively.

Financial Information · p. 204
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-02-05Prospectus
Beijing Haizhi Technology Group Co., Ltd.北京海致科技集团股份有限公司02706.HK

As of December 31, 2022, 2023, 2024, September 30, 2025 and December 31, 2025, we had redemption liabilities of nil, RMB1,459.5 million, RMB1,672.1 million, RMB2,024.8 million and RMB2,063.4 million, respectively.

Financial Information · p. 398

Our redemption liabilities increased from nil as of December 31, 2022 to RMB1,459.5 million as of December 31, 2023, primarily due to the recognition of our redemption liabilities arising from redemption rights issued to Pre-IPO Investors in 2023, as a result of the Reorganization.

Financial Information · p. 398

We had changes in the fair value of financial liabilities at fair value through profit or loss of nil, RMB19.8 million, RMB21.4 million, RMB14.6 million and RMB5.7 million in 2022, 2023, 2024 and the nine months ended September 30, 2024 and 2025, respectively.

Financial Information · p. 368
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-01-30Prospectus
Axera Semiconductor Co., Ltd.爱芯元智半导体股份有限公司00600.HK

We recorded RMB131.4 million, RMB157.7 million, RMB225.0 million, RMB164.0 million and RMB295.0 million in changes in the carrying amount of redemption liabilities in the consolidated statements of profit or loss for 2022, 2023, 2024 and the nine months ended September 30, 2024 and 2025, respectively.

Summary · p. 14

The shares with preferred rights will be reclassified from liabilities to equity upon Listing.

Summary · p. 14

Upon Listing, all of our financial instruments issued to investors will be converted into ordinary shares.

Financial Information · p. 303
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-01-29Prospectus
Distinct Healthcare Holdings Limited卓正医疗控股有限公司02677.HK

We recorded fair value loss of convertible redeemable preference shares of RMB87.4 million and RMB289.4 million in 2022 and 2023, respectively, and recorded fair value gain of convertible redeemable preference shares of RMB128.8 million, RMB80.0 million and RMB77.3 million in 2024 and the eight months ended August 31, 2024 and 2025.

Financial Information · p. 350

In addition, the issuance of certain preference shares during 2024 also decreased the fair value of convertible redeemable preference shares due to dilution effect.

Financial Information · p. 358

The convertible redeemable preference shares will be automatically converted into ordinary Shares and accounted for as an increase in share capital and share premium upon the Listing, after which we do not expect to recognize any further loss or gain on fair value changes from the convertible redeemable preference shares.

Financial Information · p. 376
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-31Prospectus

We recorded fair value loss on financial liabilities of US$60.5 million, US$176.8 million, US$214.2 million, US$128.1 million and US$313.5 million in 2022, 2023, 2024 and the nine months ended September 30, 2024 and 2025, respectively.

Financial Information · p. 423

Our convertible redeemable preferred shares further increased to US$2,321.2 million as of September 30, 2025, primarily due to (i) additional issuances of Series Pre-B+ shares totaling US$35.8 million, (ii) issuances of Series Pre-B++ shares totaling US$390.5 million, and (iii) fair value adjustments of US$313.0 million, reflecting continued increases in our valuation.

Financial Information · p. 445

These preferred shares are redeemable upon the occurrence of specified events and will be automatically converted into ordinary shares of the Company upon the completion of the Listing.

Financial Information · p. 445
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-30Prospectus
Knowledge Atlas Technology Joint Stock Company Limited北京智谱华章科技股份有限公司02513.HK

We recognized the financial instruments at present value of financial instruments, with changes in such carrying amounts being booked in profit or loss, arising from redemption rights issued to Pre-IPO Investors. These redemption rights issued will be terminated and converted into equity upon the Global Offering.

Summary · p. 15

The Convertible Bond bears interest up to 8% per annum. In May 2025, the bond holders converted all outstanding Convertible Bonds into our financial instruments issued to investors.

Financial Information · p. 284
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-22Prospectus
Shanghai Biren Technology Co., Ltd.上海壁仞科技股份有限公司06082.HK

We recorded non-current redemption liabilities of RMB7,382.2 million, RMB8,053.1 million, RMB8,743.0 million and RMB18,560.9 million, as of December 31, 2022, 2023 and 2024 and October 31, 2025, respectively.

Financial Information · p. 407

Changes in the carrying value of redemption liabilities are non-cash in nature, and the redemption liabilities will be automatically converted into the equity of our Company upon the completion of the Global Offering.

Business · p. 241
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-18Prospectus

In 2022 and 2023, we recorded fair value losses on convertible redeemable preferred shares of US$138.1 million and US$126.1 million, respectively, and we recorded a gain of US$9.0 million in 2024.

Financial Information · p. 395

This change was mainly due a smaller increase in the fair value of our preferred shares, as our market valuation was relatively stable with modest growth following completion of our Series E financing, compared to the significant valuation increases and fair value losses recorded in the first half of 2024.

Financial Information · p. 399
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us